https://www.selleckchem.com/pr....oducts/fenebrutinib-
Therefore, DPMPP has a potential to be used as a therapeutic agent for treatment of prostate cancer.This work provides the first characteristics of the rhodopsin SpaR from Sphingomonas paucimobilis, aerobic bacteria associated with opportunistic infections. The sequence analysis of SpaR has shown that this protein has unusual DTS motif which has never reported in rhodopsins from Proteobacteria. We report that SpaR operates as an outward proton pump at low pH; however, proton pumping is almost absent at neutral and alkaline
Mi piace
Commento
Condividi
